Vaccination status and outcomes of COVID-19 patients admitted to a tertiary hospital in Iran during the dominant Delta variant period.

Hamed Mehdinezhad Bardia Karim Niloufar Ahmadi Reza Mohseni Ahangar Ali Asadolahzadeh Mahmoud Sadeghi Haddad Zavareh Fatemeh Khoshkhou Zeynab Qolami Neda Mahdinezhad Gorji Mouloud Agajani Delavar

Published in: Immunity, inflammation and disease (2023)

Based on the present results, the risk of mortality and the risk of poor outcomes were lower in patients who received Remdesivir compared to those not receiving Remdesivir. The number of vaccinated patients was smaller than the unvaccinated among hospitalized patients. It is important to emphasize that vaccination reduced the need for hospitalization and that only vaccinated patients with comorbidities required hospitalization.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
adipose tissue
cardiovascular disease
metabolic syndrome
weight loss
glycemic control
patient reported